Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bempedoic acid in Taiwanese patients with hypercholesterolemia or mixed dyslipidemia
NCT06925100Phase 4Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Apr 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bempedoic acid in hypercholesterolemia, mixed dyslipidemia, sponsored by Daiichi Sankyo Co., Ltd.. Started Apr 2025; status: completed.
02
Drugs
bempedoic acid
03
Conditions
hypercholesterolemiamixed dyslipidemia
Beyond the preview
Go deeper on NCT06925100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06925100.